3rd Annual BMRP Investigator Meeting - Abstract
Deficiency of NK and CD1d-Restricted Vα24+ NK T-Cells in Crohn’s Disease and Ulcerative Colitis
Randall H. Grose, Fiona M. Thompson and Adrian G. Cumminsa
Department of Gastroenterology and Hepatology, The Queen Elizabeth Hospital (Woodville South, South Australia, Australia)
Background: A subset of immunoregulatory T-cells has the surface phenotype of Vα24+ Vβ11+ T-cells. These immunoregulatory T-cells are predominantly CD161+ NK cells and are CD1d restricted. Vα24+ T-cells are deficient in autoimmune disorders. The aim of this study was to investigate whether regulatory Vα24+ T-cells are deficient in Crohn’s disease or ulcerative colitis.
Method: Blood was collected for flow cytometry from subjects with Crohn’s disease (n=97), ulcerative colitis (n=68) and control subjects (n=152). Numbers of circulating CD56+, CD57+, CD94+, CD161+ NK cells and Vα24+, Vβ11+, Vβ13+ T-cells were determined. Intracellular IL-4 and IFN-γ production was measured after in vitro anti-CD3 antibody stimulation. Relative duplex PCR from ileal or colonic biopsy samples was used to determine Vα24 mRNA expression.
Results: CD56+, CD57+, CD94+, CD161+ NK cells were reduced to 38%, 70%, 55% and 47% in Crohn’s disease of levels in normal controls. Similarly, CD56+, CD57+, CD94+, CD161+ NK cells were reduced to 56%, 73%, 59% and 67% in ulcerative colitis subjects. Vα24+, Vα24+ CD4+, Vα24+ Vβ11+ T-cells and CD161+ Vα24+ NK T-cells were reduced to 34%, 45%, 21% and 25% of levels in normal controls, respectively, in Crohn’s disease. The Vα24+ Vβ11+ and Vα24+ Vβ11+ α-galactosylceramide/CD1d+ T-cells were 21% and 0.3% in Crohn’s disease and 15% and 7% in ulcerative colitis compared to normal subjects. IL-4 and IFN-γ production by Vα24+ T-cells were defective. Intestinal Vα24 mRNA expression from Crohn’s disease and ulcerative colitis was 15% and 29%, respectively, of levels in normal subjects.
Conclusion: We conclude that NK cells are deficient in Crohn’s disease and in ulcerative colitis. Vα24+ T-cells are deficient and functionally defective in Crohn’s disease and are selectively and mucosally deficient in ulcerative colitis. Vα24+ Vβ11+ and Vα24+ Vβ11+ α-galactosylceramide/CD1d tetramer+ cells are deficient in both Crohn’s disease and ulcerative colitis. This decrease in immunoregulatory cells may contribute to the pathogenesis of IBD.
aPrincipal Investigator
